EPRD focuses its research effort in areas of embryology, andrology, cryopreservation, idiopathic infertility, reproductive genetics and novel technologies IVF. Most of EPRDs research is based on the small research projects in-built within the two coursework degrees: GradDipRepSi and MClinEmb. However EPRD staff also take on a limited number of honours, MRepSc and PhD students in the following areas:
- Idiopathic infertility
- Sperm DNA damage analysis
- Oocyte and embryo vitrification
- Fertility preservation
- Vitrification of ovarian tissue and follicles
- In vitro oocyte maturation and In vitro and in vivo growth of follicles
- Novel technologies for improving embryo culture and embryo selection
- Reproductive genetics
- Artificial intelligence in IVF
Industry/Commercialisation /Investment/Contract Research Opportunities
EPRD is currently involved with the following organisations in relation to product testing, research development and commercialisation:
- Peranta Biosciences
- Melbourne Aquarium
- Melbourne Institute of Plastic Surgery
- APSEF (Advanced Plastic Surgery Education Foundation)
- IVF supply companies - Cook, Origio, LifeGlobal, Sage, Gytec, Kitazato, Tek-event
- ESCO Global
- Ferring pharmaceuticals
- Monash IVF
Current grants and projects
We are currently developing the following projects
- Ferring Australia grant for the study “Oocyte DNA repair capacity in infertile couples”. Chief investigator: Dr Fabrizzio Horta, Dr Sally Catt, A/Prof Peter Temple-Smith and Prof Beverley Vollenhoven. Total funding: for 23,000 AUD
- Monash IVF grant for the study “Which factors are associated with recurrent implantation failure?”. Chief investigator: Dr Fabrizzio Horta, Prof Ben W Mol, Dr Sally Catt, A/Prof Peter Temple-Smith and Prof Beverley Vollenhoven. Total funding: 35,000 AUD
- Monash IVF grant for the study “Novel methods of cryopreservation of ovarian tissue”. Chief investigator: Dr Sally Catt, Dr Fabrizzio Horta, Dr Kiri Bielby, A/Prof Peter Temple-Smith and Prof Beverley Vollenhoven. Total funding: 25,000 AUD
- International Ferring COVID-19 investigational grant in reproductive medicine and maternal health for the study “Incidence of natural conception in infertile couples schedule for ART treatment during fertility clinic COVID-19 in Australia/New Zealand”. Chief investigator: Dr Fabrizzio Horta, Elizabeth Cutting, Prof Ben W Mol. Total funding: 8,500 AUD
- Reappraisal of the mechanisms underlying implantation success or failure. Salamonsen, L., Greening, D. W., Evans, J., Simpson, R., Catt, S., Vollenhoven, B. National Health and Medica Research Council (NHMRC). Total funding: 750,754 AUD.
- The central role of accelerated trophoblast syncytialization and aging in preeclampsia. Nie, G. and Catt, S. National Health and Medica Research Council (NHMRC). Total funding: 856,540 AUD.
- Non-invasive metabolic imaging of oocytes and early embryo development. Chief investigators: Dr Fabrizzio Horta, Dr Sally Catt, Prof Beverley Vollenhoven, Prof Adrian Neild, Dr Reza Nosrati, Dr Victor Cadarso.
- Development of embryo culture media to improve DNA repair capacity in aged females. Chief investigators: Dr Fabrizzio Horta, Dr Sally Catt, A/Prof Peter Temple-Smith, Prof Beverley Vollenhoven.
- Machine learning for Clinical Decision support in in-vitro fertilisation. Chief investigators: Dr Fabrizzio Horta, Dr Hamid Rezatofighi, Dr Sally Catt, Prof JianFei Cai, Prof Beverley Vollenhoven.